Deals > All

East Germany North Germany South Germany West Germany Austria Germany Switzerland [ # 12 & 35 ]

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3757 | Ordered by Date (descending)
1 2 3 ... 23 24 25 ... 36 37 38

Deal: Collaboration or Financing	Date
SmartDyeLivery–PERSON: investment, 201810 financing round from bm\|t + business angel from Munich	2018-10-10
SmartDyeLivery–SEVERAL: investment, 201810 financing round from bm\|t + business angel from Munich	2018-10-10
SmartDyeLivery–Thuringia (govt): investment, 201810 financing round from bm\|t + business angel from Munich	2018-10-10
DSM–Lipotype: mass spectrometry services, 201810 collab supply of shotgun skin lipidomics services by Lipotype to Royal DSM	2018-10-08
Lipoid–Lipotype: mass spectrometry services, 201810 collab supply of shotgun skin lipidomics services by Lipotype to Lipoid GmbH	2018-10-08
Sphingotec–HBM: investment, 201810 financing round totalling €20m incl co-lead investor HBM	2018-10-08
Sphingotec–SEVERAL: investment, 201810 financing round €20m co-led by HBM + Wellington Partners	2018-10-08
Sphingotec–Wellington Partners: investment, 201810 financing round totalling €20m incl co-lead investor Wellington Partners	2018-10-08
Axcelead–ERS Genomics: CRISPR technology, 201810– license non-excl ww to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd	2018-10-04
GenAhead Bio–ERS Genomics: CRISPR technology, 201810– license non-excl to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd	2018-10-04
Sanofi–Evotec: drug discovery, 201810– collab partnership BRIDGE LAB031 for early-stage projects out of academic research	2018-10-04
Curetis–Yorkville Group: credit, 201810– up to €20m convertible notes with attached warrants to YA II PN Ltd	2018-10-02
Oncgnostics–Biotech Alliances International: business services, 201810– supply service support for global partnering + distribution strategy	2018-10-02
Roche–GO Therapeutics: antibody cancer drug, 201810– license ww excl $9m upfront/near-term +$186m milestones + royalties for bispecific antibody	2018-10-02
Sartorius–Genedata: bioinformatics, 201810 collab product integration of Genedata Bioprocess s/w with ambr mini bioreactors	2018-10-02
Atai Life Sciences–SEVERAL: investment, 201810 1st financing round €21.2m from private investors	2018-10-01
B Braun–CeGaT: personalised medicine, 201810 collab establishment JV to develop personalised cancer vaccines CeCaVa GmbH & Co KG	2018-10-01
Forbion–SEVERAL: investment, 201810 final close €360m of Forbion IV fund	2018-10-01
Helmholtz–Bruker: MRI system, 201810 supply 9.4 Tesla preclinical MRI system with integrated PET detector to DKFZ	2018-10-01
Neuron23–SEVERAL: investment, 201810c financing round Series A $33.5m from Westlake Village BioPartners + Kleiner Perkins	2018-10-01
Novaliq–Hopp Group: investment, 201810 financing round €44.9m from Dievini Hopp BioTech Holding GmbH	2018-10-01
Strüngmann Group–Cyclenium: anti-infectives, 201810– collab discovery using CMRT technology + QUEST Library with AiCuris	2018-10-01
Pfizer–Qiagen: companion diagnostics, 201809 collab existent CDx for precision medicines in onocology	2018-09-28
Tusk Therapeutics–Roche: investment, 201809 acquisition for €70m cash + €585m milestones with some assets spun out into Black Belt Therapeutics	2018-09-28
Bayer–Genedata: bioinformatics, 201809– license to Genedata Selector s/w for Bayer CropScience division for develop new fungicides	2018-09-27
Bayer–Inova Software: business development software, 201809 supply existent Bayer is user of Inova Partnering Platform	2018-09-27
Lilly–Inova Software: business development software, 201809 supply existent Lilly is user of Inova Partnering Platform	2018-09-27
Novartis–Inova Software: business development software, 201809 supply existent Novartis is user of Inova Partnering Platform	2018-09-27
Roche–Inova Software: business development software, 201809 supply existent Roche is user of Inova Partnering Platform	2018-09-27
TTP Group–Battery Ventures: investment, 201810 acquisition €na of TTP Labtech from TTP Group by Battery Ventures	2018-09-27
Genewiz–Brooks Automation: investment, 201809– acquisition $450m of Genewiz by Brooks ANNOUNCED	2018-09-26
Minoryx–SEVERAL: investment, 201809 financing round Series B €21.3m led by Fund+ with SFPI + SRIW + Sambrinvest + all Series A investors	2018-09-26
Valneva–SEVERAL: investment, 201809 private placement €50m with 13.33m new ordinary shares at €3.75/share led by US healthcare investors	2018-09-26
Aktiia–Redalpine: investment, 201809 seed financing round totalling CHF4m led by TransLink Capital + Redalpine	2018-09-25
Aktiia–SEVERAL: investment, 201809 seed financing round CHF4m led by TransLink Capital + Redalpine	2018-09-25
Aktiia–TransLink Capital: investment, 201809 seed financing round totalling CHF4m led by TransLink Capital + Redalpine	2018-09-25
Sachem–Thermo FIsher: mass spectrometer, 201809 supply existent ISQ EM single quad system early customer	2018-09-24
Tolremo Therapeutics–Altos Venture: investment, 201809 financing round Series A totalling CHF9m incl new + co-investor Altos Venture	2018-09-24
Tolremo Therapeutics–BioMedPartners: investment, 201809 financing round Series A totalling CHF9m incl new + lead investor BioMedPartners	2018-09-24
Tolremo Therapeutics–Redalpine: investment, 201809 financing round Series A totalling CHF9m incl new + co-investor Redalpine	2018-09-24
Tolremo Therapeutics–SEVERAL: investment, 201809 financing round Series A CHF9m led by BioMedPartners	2018-09-24
Tolremo Therapeutics–Zürcher Kantonalbank: investment, 201809 financing round Series A totalling CHF9m incl exisintg + co-investor ZKB	2018-09-24
India (govt)–Thermo Fisher: mass spectrometry, 201809 collab food testing solutions using MS + chromatography with FSSAI	2018-09-20
Plug and Play–Roche: healthcare, 201809–202108 collab creation of Startup Creasphere innovation program in Munich with Roche Diagnostics	2018-09-20
Univ Salzburg–Thermo Fisher: mass spectrometry, 201809 collab biopharma characterisation with LC-MS with CDL at Univ Salzburg	2018-09-20
CRISPR Therapeutics–SEVERAL: investment, 201809 public offering $200m net $185.7m with 4.21m common shares at $46.5/share	2018-09-19
BluCon Biotech–BRAIN Biotech: industrial biotechnology, 201809– strategic research collab microbial strain developm for PLA-based bioplastic	2018-09-18
GeNeuro–Servier: investment, 201809 existent investor Servier	2018-09-18
Almirall–Evotec: drug discovery services, 201809– collab RnD therapies for dermatological diseases	2018-09-17
BioPhero–SEVERAL: investment, 201809 seed financing round €3m from Novo Seeds + Syngenta Ventures + Syddansk Innovation	2018-09-17
Iowa State Univ–Thermo Fisher: mass spectrometry, 201809 supply existent early user of new VetDrugs Explorer Collection LC-MS/MS solution	2018-09-17
Luciole Medical–SEVERAL: investment, 201809 financing round Series A CHF5.3m (€4.7m) led by SVC Ltd (CreditSuisse)	2018-09-17
NeuMoDx–Qiagen: investment, 201809 existent Qiagen owns 19.9% of NeuMoDx	2018-09-17
NeuMoDx–Qiagen: investment, 201809– option to acquire remaining 80.1% of NeuMoDx for $234m	2018-09-17
Qiagen–NeuMoDx: molecular diagnostics, 201809– collab distribution outside US by Qiagen + implementation of Qiagen reagents on NeuMoDex PRC systems	2018-09-17
Coda Biotherapeutics–SEVERAL: investment, 201809 financing round Series A $19m co-led by MPM Capital + Versant Ventures	2018-09-12
Merck (DE)–AstraZeneca: digital pathology, 201809– collab multi-year partnership with Definiens using TissuePhenomics for biomarker quantification	2018-09-10
RSP Systems–SEVERAL: investment, 201809 financing round Series B 2nd closing €3.85m incl new investor Trumpf Venture GmbH	2018-09-10
RSP Systems–Trumpf: investment, 201809 financing round Series B 2nd closing totalling €3.85m incl new investor Trumpf Venture GmbH	2018-09-10
Menarini–Lunaphore: staining technology, 201809– collab Menarini Diagnostics to market LabSat Frozen tissue staining solution	2018-09-09
Celgene–Evotec: drug discovery services, 201809– strategic RnD collab in field of targeted protein degradation using Panomics platform	2018-09-06
Novartis–Aurobindo: investment, 201809 acquisition $900m cash + $100m milestones of Sandoz US dermatology + oral generics businesses by Aurobindo USA	2018-09-06
Polyphor–Novo Group: investment, 201809 capital increase CHF6.8m with 179k shares at CHF38/share sold to Novo REPAIR Impact Fund	2018-09-06
Polyphor–Novo Group: investment, 201809– project-based + royalty-bearing investment up to CHF4.7m based on milestones in OMPTA program by Novo REPAIR	2018-09-06
Twentyeight-Seven–Astellas: investment, 201809 financing round Series A totalling $65m incl co-investor Astellas Venture Management	2018-09-06
Twentyeight-Seven–JnJ: investment, 201809 financing round Series A totalling $65m incl co-investor JnJ Innovation JJDC Inc	2018-09-06
Twentyeight-Seven–Longwood Fund: investment, 201809 financing round Series A totalling $65m incl co-investor Longwood Fund	2018-09-06
Twentyeight-Seven–MPM Capital: investment, 201809 financing round Series A totalling $65m incl founding + co-lead investor MPM Capital	2018-09-06
Twentyeight-Seven–Novartis: investment, 201809 financing round Series A totalling $65m incl co-lead investor NVF	2018-09-06
Twentyeight-Seven–SEVERAL: investment, 201809 financing round Series A $65m co-led by founding investor MPM Capital + NVF	2018-09-06
Twentyeight-Seven–Temasek: investment, 201809 financing round Series A totalling $65m incl co-investor Vertex Ventures HC	2018-09-06
Creoptix–Waters: investment, 201809 investment by new investor Waters Corp	2018-09-05
Miracor–SEVERAL: investment, 201809 financing round Series D totalling €30m final closing led by Ming Capital (CN)	2018-09-04
Mologen–SEVERAL: investment, 201809 capital increase €8.2m with 1.73m new shares at €4.7/share to existing + new investors	2018-09-03
CHDI–Evotec: drug discovery services, 201808–2023 collab service extension CDHI funding up to 75 full-time scientists for Huntington’s disease drugs	2018-08-30
Lunaphore–SEVERAL: investment, 201808 financing round Series B CHF5.3m from existing + new investors	2018-08-30
Nebula Genomics–Heartbeat Labs: investment, 201808 seed financing round totalling $4.3m incl Heartbeat Labs	2018-08-29
Nebula Genomics–SEVERAL: investment, 201808 seed financing round $4.3m from ten leading tech + biotech VCs	2018-08-29
PhagoMed–Austria (govt): grant, 201808–2021 research project grant €3.5m from FFG	2018-08-28
PhagoMed–Austria (govt): investment, 201808 seed financing round totalling €1.55m incl €800k aws-Seedfinancing	2018-08-28
PhagoMed–OTHER: investment, 201808 seed financing round totalling €1.55m incl €750k from private investors	2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round €1.55m from private investors + aws	2018-08-28
Evotec–Centogene: drug discovery, 201808– collab ww strategic €na discovery + developm of treatments for rare genetic diseases	2018-08-27
Proteomedix–Altos Venture: investment, 201808 financing round totalling CHF5.2m incl exising + lead investor Altos Venture	2018-08-27
Proteomedix–SEVERAL: investment, 201808 financing round CHF5.2m from exising investors led by Altos Venture + incl ZKB	2018-08-27
Proteomedix–Zürcher Kantonalbank: investment, 201808 financing round totalling CHF5.2m incl exising + co-investor ZKB	2018-08-27
Roche–Affimed: antibody cancer drug, 201808– collab $96m ufpront + $5b milestones + royalties using ROCK platform to develop ABs with Genentech	2018-08-27
Thermo Fisher–BioStrata: public relations, 201808 service existent by BioStrata	2018-08-27
Univ Wisconsin–Thermo Fisher: FAIMS technology, 201808 supply use of FAIMS device for shotgun proteomics by Joshua Coon	2018-08-27
Hain Lifescience–Bruker: investment, 201808– acquisition €na of 80% majority interest with option to acquire rest in 2012 ANNOUNCED	2018-08-24
c-LEcta–Capricorn Venture Partners: investment, 201808 financing round incl new + lead investor Capricorn investing via CSCF NV + Quest for Growth	2018-08-23
c-LEcta–SEVERAL: investment, 201808 financing round €na with new investors Capricorn Venture Partners + bm\|t	2018-08-23
c-LEcta–Thuringia (govt): investment, 201808 financing round incl new + co-investor bm\|t via MFT Mittelstands-Fonds Thüringen	2018-08-23
Novaremed–SEVERAL: investment, 201804 financing round CHF4.44m to support phase 2b study of NRD.E1 in DNP	2018-08-23
Novaremed–SEVERAL: investment, 201808 financing round CHF6m to support phase 2b study of NRD.E1 in DNP	2018-08-23
Merck (DE)–GlucoMe: digital health, 201808– collab digital diabetes management project in Vietnam	2018-08-22
Novo Group–Evotec: drug discovery services, 201808– collab €na strategic alliance RnD small molecule drugs for diabetes + obesity Novo Nordisk	2018-08-22
SolasCure–Brain Biotech: investment, 201808–202108 financing round Series A totalling £15m incl lead investor Brain Biotech AG	2018-08-22
SolasCure–BRAIN Biotech: wound care product, 201808– license IP for Aurase enzyme + supply of enzymatic active ingredient by BRAIN to SolasCure	2018-08-22
SolasCure–SEVERAL: investment, 201808–202108 financing round Series A £15m led by Brain Biotech AG	2018-08-22

1 2 3 ... 23 24 25 ... 36 37 38

Picture [iito] No Content Marketing 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)